Koninklijke Philips (RYLPF) Cash from Discontinued Operations (2009 - 2025)
Koninklijke Philips (RYLPF) recorded quarterly Cash from Discontinued Operations of 11640435.15 in Q4 2025, little changed quarter-over-quarter from 11690550.91 in Q3 2025, and up 16.21% on a YoY basis from 10017062.97 in Q4 2024.
Koninklijke Philips (RYLPF) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends
Koninklijke Philips' Cash from Discontinued Operations history runs 17 years deep, the most recent figure standing at 11640435.15 for Q4 2025.
- In Q4 2025, Cash from Discontinued Operations rose 16.21% year-over-year to 11640435.15; the TTM figure through Dec 2025 stood at 45169427.34 (up 34.85% YoY), while the FY2024 annual figure was 13891740.2, down 110.5% from the prior year.
- Cash from Discontinued Operations was 11640435.15 for Q4 2025 at Koninklijke Philips, roughly flat from 11690550.91 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 4552049064.24 in Q3 2021 to a low of 61889287.92 in Q2 2022.
- Historically, Cash from Discontinued Operations has averaged 424390806.45 across 5 years, with a median of 10919220.64 in 2025.
- The sharpest annual moves came in 2021 and 2024: Cash from Discontinued Operations jumped 2431.08% in 2021, then plunged 330.16% in 2024.
- A 5-year view of Cash from Discontinued Operations shows it stood at 3892933146.71 in 2021, then slumped by 100.31% to 12242968.38 in 2022, then jumped by 275.76% to 21518798.18 in 2023, then sank by 164.56% to 13891740.2 in 2024, then increased by 16.21% to 11640435.15 in 2025.
- The last three Cash from Discontinued Operations figures came in at 11640435.15 (Q4 2025), 11690550.91 (Q3 2025), and 11319596.88 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.64 Mn |
| Dec 31, 2025 | -11.64 Mn |
| Sep 30, 2025 | -11.69 Mn |
| Sep 30, 2025 | -11.69 Mn |
| Jun 30, 2025 | -11.32 Mn |
| Jun 30, 2025 | -11.32 Mn |
| Mar 31, 2025 | -10.52 Mn |
| Mar 31, 2025 | -10.52 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Sep 30, 2024 | -18.67 Mn |
| Sep 30, 2024 | -18.67 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Mar 31, 2024 | -18.47 Mn |
| Mar 31, 2024 | -18.47 Mn |
| Dec 31, 2023 | 21.52 Mn |
| Dec 31, 2023 | 21.52 Mn |
| Sep 30, 2023 | 87.09 Mn |
| Sep 30, 2023 | 87.09 Mn |